Individual participant data sharing intentions and practices during the coronavirus disease-2019 pandemic: A rapid review

Abstract

The coronavirus disease-2019 (COVID-19) pandemic has led to the irrational use of drugs in the absence of clinical management guidelines. Access to individual participant data (IPD) from clinical trials aids the evidence synthesis approaches. We undertook a rapid review to infer IPD sharing intentions based on data availability statements by the principal investigators (PIs) of drug and vaccine trials in the context of COVID-19.

Keywords

• COVID-19
• data sharing
• individual participant data
• randomized controlled trials
• rapid review
• vaccine trials